How Much Ozempic Do I Take for Weight Loss?

Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has shown significant weight loss benefits in clinical trials. Understanding how dosing works—and why it starts low and increases gradually—helps you set realistic expectations for your weight loss journey. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies, with transparent, dose-independent pricing.

Understanding Semaglutide Starting Doses and Titration

Semaglutide weight loss treatment begins with a low dose to minimize gastrointestinal side effects and allow your body to adapt. The standard starting dose is 0.25 mg injected subcutaneously once weekly. This introductory phase typically lasts 4 weeks, after which your dose increases by 0.25 mg every 4 weeks until reaching your target maintenance dose. Most people find their therapeutic sweet spot between 1.0 mg and 2.4 mg weekly, depending on individual response and tolerability.

The gradual titration schedule serves a clinical purpose: it reduces nausea, vomiting, and appetite suppression that can feel overwhelming at higher doses. Your healthcare provider monitors your progress during this ramp-up period and may slow the escalation if you experience significant side effects. This personalized approach means no two patients follow identical timelines, but the underlying principle remains consistent—start low, go slow, find your dose.

Typical Semaglutide Dosing Schedule and Timeline

A conventional semaglutide dosing protocol spans approximately 16–20 weeks from initiation to maximum dose. Week 1–4: 0.25 mg weekly. Week 5–8: 0.5 mg weekly. Week 9–12: 1.0 mg weekly. Week 13–16: 1.7 mg weekly. Week 17+: 2.4 mg weekly (the maximum FDA-studied dose for weight loss). Some patients achieve their goal weight before reaching 2.4 mg and may remain stable at a lower maintenance dose indefinitely.

The timing of your weekly injection matters for consistency: most people select the same day each week and administer their injection on the abdomen, thigh, or upper arm. You can rotate injection sites to prevent lipodystrophy (localized fat changes). If you miss a dose, take it as soon as you remember, following the missed-dose instructions on your pharmacy label—in that case, skip the missed dose and resume your regular schedule.

How Your Body Responds at Different Semaglutide Dose Levels

At lower doses (0.25–0.5 mg), appetite suppression is mild, and most patients report subtle changes in food preferences and portion control. Nausea, if present, is usually minimal. As you progress to moderate doses (1.0–1.7 mg), appetite reduction becomes more pronounced, and many people naturally eat 30–50% fewer calories without conscious restriction. Gastrointestinal side effects peak during titration and often improve once your body acclimates to a stable dose.

At higher maintenance doses (2.0–2.4 mg), weight loss velocity typically plateaus compared to earlier phases, but metabolic benefits continue accumulating. Some patients report enhanced satiety, reduced cravings for specific foods (especially sweets and highly processed items), and improved blood sugar control. The "sweet spot" dose for any individual is highly variable—some people lose substantial weight at 1.0 mg, while others need closer to 2.0 mg for meaningful results.

Personalized Dosing: Why Your Genetics and Metabolism Matter

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Understanding your genetic makeup removes guesswork from dosing decisions. Patients with high-responder genotypes may achieve weight loss goals at lower doses with fewer side effects, while those with lower-responder profiles may require slower titration or different timing strategies. This personalized approach aligns with precision medicine principles and maximizes your likelihood of sustainable success. The $298 genetic test (available as an add-on after your first month of PlexusDx treatment) provides data-driven guidance for your entire weight loss protocol.

Semaglutide Dosing Flexibility and Long-Term Maintenance

Once you reach a maintenance dose, your injection schedule remains unchanged—one injection per week at your established dose. However, dosing is not permanent or fixed. If you experience persistent side effects, your provider may recommend stepping back to a lower dose that still produces meaningful weight loss. Conversely, if you plateau in weight loss after several months, a dose increase may re-engage appetite suppression and metabolic benefits.

Long-term semaglutide therapy is typically continued indefinitely because weight regain occurs in most patients after discontinuation. Your dose may remain stable for months or years, or it may shift based on your life circumstances, other medications, or metabolic changes. PlexusDx delivers your chosen semaglutide dose at a flat monthly rate of $149-$189 (depending on your commitment tier), ensuring your price never climbs as your clinical dose changes.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will my semaglutide dose increase every month?

No. Semaglutide dosing increases every 4 weeks during an initial titration phase (typically 4–5 months), then stabilizes at your maintenance dose. Most people remain on the same weekly injection amount long-term unless side effects or plateauing weight loss prompt an adjustment.

What dose of semaglutide is most effective for weight loss?

Clinical trials demonstrate that 2.4 mg weekly produces the greatest average weight loss (around 15% body weight), but effective doses range from 1.0 to 2.4 mg depending on individual tolerance and response. Your provider tailors your dose based on your results and side effect profile, not a one-size-fits-all target.

Does PlexusDx charge more if I'm on a higher semaglutide dose?

No. PlexusDx compounded semaglutide injections cost a flat $189/mo (or $149/mo on the 6-month plan) across all commitment tiers, regardless of whether you're taking 0.25 mg or 2.4 mg weekly. Your dose may go up, but your price won't.

What happens if I can't tolerate a semaglutide dose increase?

Your provider can pause the titration and let you stabilize at your current dose for an additional 4 weeks before attempting another increase. Some patients remain on lower doses (0.5–1.0 mg) long-term with excellent results and minimal side effects. There is no requirement to reach 2.4 mg.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

Yes. PlexusDx Precision Peptide Genetic Test examines variants in GIPR and FTO, and MC4R pathways to reveal your genetic responsiveness to semaglutide. This insight ($298) helps your provider anticipate your dose requirements and optimize your personalized protocol.

How often should I see my doctor while dosing up on semaglutide?

Most providers recommend check-ins every 4 weeks during titration and every 6–12 weeks once you reach maintenance dose. PlexusDx works with your personal prescriber and coordinates with licensed 503A compounding pharmacies to ensure continuous, safe medication access across all 50 states—no membership fees required.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.